Vanguard Group »

Eterna Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Eterna Therapeutics (ERNA) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Eterna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eterna Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eterna Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $47k 26k 1.80
2023-09-30 $54k 25k 2.18
2023-06-30 $43k 19k 2.26
2023-03-31 $65k 19k 3.40
2022-12-31 $94k 29k 3.22